The annual physical is a reasonable piece of medicine doing a specific job. Understanding what that job is — and what falls outside it — explains why a clean bill of health can coexist with an unclear picture of your trajectory.
What it’s designed to do
Preventive care guidelines are built around population screening. The logic is essentially actuarial: given a population, which tests detect conditions early enough that detection changes outcomes, at a cost the system can bear, without generating so many false positives that the harm from unnecessary follow-up outweighs the benefit?
That framework produces sensible recommendations. Blood pressure checks, cholesterol screening at intervals, colorectal and cervical cancer screening at defined ages, mammography by guideline.
It’s evidence-based and it saves lives. It’s also optimized for a different question than the one many people are actually asking.
Screening asks: does this person have a detectable condition that warrants intervention? It answers yes or no. It doesn’t characterize the physiology of someone who answers no.
What typically isn’t included
Fasting insulin. Glucose is measured; insulin usually isn’t. Insulin resistance can precede glucose elevation by years.
Body composition. Weight and often BMI get recorded. The distinction between muscle and fat, and the location of that fat, generally doesn’t.
Waist circumference. Takes thirty seconds with a tape measure and predicts metabolic risk better than BMI. Frequently skipped.
Cardiorespiratory fitness. VO₂ max has one of the strongest associations with all-cause mortality of any single measure, and is almost never assessed in primary care.
Strength. Grip strength requires an inexpensive device and correlates with functional outcomes. Rarely measured.
ApoB or lipoprotein(a). The standard lipid panel doesn’t include either. Lp(a) is genetically determined, meaningfully associated with cardiovascular risk, and needs measuring only once.
Sleep. Rarely assessed beyond a passing question, if that. Sleep apnea is common and frequently undiagnosed.
Bone density before guideline age. Screening typically starts around 65 in women, decades after loss begins.
Detailed hormonal assessment. Generally only pursued when symptoms prompt it.
Balance and mobility. Predictive of falls, which are a major cause of loss of independence.
The reference range issue
Even for what is measured, interpretation carries a limitation worth understanding.
Reference ranges are derived from population distributions — typically the middle portion of values from a sampled group. They describe what’s common, which in a population where metabolic dysfunction is widespread isn’t the same as what’s optimal.
They also generate a binary. A value inside the range produces no comment. A value outside prompts action.
That framing loses two things. It loses the difference between sitting at the healthy edge of a range and sitting at the concerning edge — both are “normal.” And it loses direction, which is often the more informative signal. A value that has moved steadily across the range over five annual visits is telling you something that no single in-range result conveys.
The other structural constraint
Primary care visits are short. Typical appointment length in many systems leaves limited time to review history, address the concerns you brought, order and interpret tests, and discuss anything else.
Under that constraint, in-range results get a brief acknowledgment. There isn’t room to step back and ask what four borderline values in the same person, all pointing at the same physiology, might mean together.
This isn’t a failure of the clinicians involved. It’s what the format permits.
What a different approach looks like
Comprehensive assessment asks a different question: not “is anything wrong?” but “what is this person’s physiological state and where is it heading?”
In practice that means broader measurement — including markers that move earlier than the diagnostic ones — read as a pattern rather than line by line, tracked over time so that direction becomes visible, and interpreted against your history and goals rather than only against a population reference range.
It also means enough time to actually discuss the results and what, if anything, follows from them.
Both, not either
None of this argues against standard preventive care. Guideline-based screening is well-supported and worth doing. Colorectal screening at the recommended age, blood pressure monitoring, appropriate cancer screening — these have strong evidence and should not be skipped in favor of anything else.
The two approaches answer different questions. One asks whether you’ve crossed a threshold that requires treatment. The other asks what your trajectory looks like while you haven’t.
Most people have only ever been asked the first.
Understanding where you stand today is the first step. A comprehensive assessment looks at these markers together, in the context of your history and your goals.
This article is general education from the Nextgenlongevityhealth clinical team. It is not medical advice, does not establish a provider–patient relationship, and is not a substitute for evaluation by a licensed clinician who knows your history. If you are experiencing a medical emergency, call your local emergency number.